Current low SARS-CoV-2 transmission rates and the absence of any highly virulent or transmissible new coronavirus strain underpin the 94.5% market-implied probability against a new pandemic in 2026. Official CDC and WHO surveillance through mid-May shows test positivity near 1%, declining infections across most U.S. states, and dominance of Omicron subvariants such as XFG.1.1 and BA.3.2 that cause mild illness comparable to recent seasonal patterns. Global case counts remain far below pandemic thresholds, supported by improved immunity from prior infections and updated 2025–2026 vaccines. Traders recognize that while viral evolution continues and novel zoonotic spillovers remain possible, no data yet indicate the rapid escalation required for a declared pandemic this year. Continuous genomic monitoring and wastewater trends will provide the next key signals for any shift in risk.